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Abstract 
Attention Deficit/Hyperactivity Disorder (ADHD) is 
characterised by developmentally inappropriate 
levels of inattention, impulsivity and hyperactivity. 
As might be expected of a disorder in which 
inhibitory deficits form part of the diagnostic 
criteria, deficits in response inhibition in ADHD 
have been evidenced in a number of studies. To 
date, the tasks used in such studies have required 
participants to inhibit the learned stimulus-response 
associations that result in unwanted behavior. 
However, no research has examined the inhibition 
of stimulus-stimulus associations, formally 
‘conditioned inhibition’. The present study used 
video game style conditioned inhibition procedures, 
developed for children and adolescents with a 
clinical diagnosis of ADHD and suitable for 
typically developing matched controls. Two 
computer-based tasks (‘Mission to Mars’ and 
‘Weapon-X’) required participants to predict the 
occurrence of an outcome based on the stimuli 
presented. We selected 12 male participants with 
ADHD on medication (methylphenidate), but 
without comorbid Tourette Syndrome, pervasive 
developmental disorder, learning disability or 
psychosis. This group showed overall normal 
inhibition of stimulus-stimulus associations, 
measured repeatedly over trials and with two task 
variants. There was no correlation between 
inhibitory learning and symptom severity ratings. 
However, participants with ADHD on higher 
dosages of methylphenidate, or longer duration of 
treatment with methylphenidate, showed improved 
ability to anticipate outcomes following the different 
stimulus presentations on non-inhibited versus 
inhibited trials. This effect was most clearly 
demonstrated on the Weapon-X task. Thus, 
methylphenidate dose-relatedly improved the 
expression of associative learning. This action may 
contribute to its therapeutic effects in improving 
cognitive function in ADHD.  
 
Key words: ADHD; associative learning; conditioned 
inhibition; methylphenidate. 
1. Introduction 
Attention Deficit/Hyperactivity Disorder (ADHD) is a 
pervasive neurodevelopmental disorder characterised 
by developmentally inappropriate levels of inattention 
and hyperactivity/impulsivity [1,2,3]. The prevalence 
of ADHD has been variably estimated as high as 10%-
18% [4,3], but is generally considered to be around 3-
5% [1].  
As might be expected, a variety of experimental tasks, 
principally the „stop signal‟ and „Go/No-Go‟ task, have 
demonstrated deficits in response inhibition in children 
with ADHD [5,6,7,8,9,10]. From a learning theory 
perspective, these procedural tasks have the common 
feature that successful performance requires inhibition 
of prepotent stimulus-response (S-R) associations.  
There have been few studies of stimulus-stimulus (S-S) 
learning in ADHD. Since the neural circuitries 
necessary for S-R and S-S associations are not 
equivalent, we cannot assume that the latter will also 
be abnormal in ADHD. In a study of blocking, Oades 
and Müller [11] found that the establishment of a prior 
S-S association was no bar to learning about an 
additional (redundant) stimulus in children with ADHD 
compared to matched controls. However, although the 
demonstration of blocking is based on S-S associations, 
the effect is not generally considered to be mediated by 
inhibition from the earlier association [12,13,14]. To 
our knowledge, no research has examined the 
inhibition of S-S associations (formally „conditioned 
inhibition‟) in ADHD. In conditioned inhibition 
procedures, a conditioned stimulus (CS) is presented 
immediately prior to an unconditioned stimulus (UCS), 
except on those occasions when it is preceded by the 
conditioned inhibitor (CI). Thus, the CI comes to 
inhibit the CS-UCS association [15]. We have 
developed video game style conditioning procedures 
that demonstrate reliable conditioned inhibition and are 
suitable for younger participants [16,17]. In both tasks, 
summation tests measure the generalisation of the 
inhibitory properties of the CI to additional stimuli: a 
novel stimulus that does not appear at all in the training 
phase but is sufficiently similar to produce generalised 
responding (Sg); and a transfer stimulus (CSt) that does 
not appear with the CI in the training phase. In both 
summation test variants, conditioned inhibition is 
demonstrated by a significant difference in the 
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direction of UCS reinforced stimuli receiving higher 
expectancy ratings than non-reinforced stimuli 
presented with the pre-trained CI.  
Table 1: Demographics, details of medication with methylphenidate, and symptom scores for the AD 
 
HD participants.  
  
Participants 1 2 3 4 5 6 7 8 9 10 11 12 
Age (months) 201 190 161 141 144 167 169 190 145 142 153 194 
IQ (WASI) 75 87 77 108 79 98 77 103 94 105 104 85 
M
e
d
ic
a
ti
o
n
 
Dosage (mg/kg) 0.85 1.08 1.93 1.03 0.82 0.89 0.77 0.57 1.33 0.83 1.23 1.42 
Medication duration (months) 63 41 51 5 19 22 18 92 11 54 59 27 
Medication duration corrected for 
age 
0.31 0.22 0.32 0.04 0.13 0.13 0.11 0.48 0.08 0.38 0.39 0.14 
C
P
R
S
-R
: 
L
 
 Oppositional 80 84 90 87 85 90 89 54 83 85 75 90 
 Cognitive Problems 62 74 74 59 78 75 77 57 63 74 78 77 
 Hyperactivity 85 57 85 87 90 90 90 80 85 90 80 90 
 Anxious 54 44 61 45 79 90 47 51 63 45 63 68 
 Perfectionism 65 43 49 69 77 77 55 50 58 41 69 52 
 Social Problems 72 60 73 69 65 90 81 90 45 90 77 80 
 Psychosomatic 61 61 42 63 88 90 90 90 58 48 83 58 
 ADHD Index 70 77 77 73 77 83 79 60 75 82 76 75 
 Global Restless Score 63 70 86 77 82 90 86 70 80 86 75 81 
 Emotional Lability 90 73 83 78 72 90 83 61 72 72 83 79 
 Global Total 72 72 88 80 81 90 88 69 80 84 80 83 
 DSM Inattentive 69 76 77 65 80 81 71 58 65 80 77 78 
 DSM Hyperactive 86 63 81 87 90 90 87 81 81 90 81 90 
 DSM Total 78 73 81 77 88 90 80 69 74 90 81 89 
 DSM Inattentive Count 8 9 9 7 9 8 8 2 6 9 9 9 
 DSM Hyperactivity Count 6 2 7 9 9 9 9 6 7 9 8 8 
Legend: ADHD = Attention Deficit/Hyperactivity Disorder; mg/kg = milligrams medication per kilogram body weight dosage per day; CPRS-R: L = 
Conners‟ Parent Rating Scale – Revised: Long; WASI: Wechsler Abbreviated Scale of Intelligence. With the exception of the bottom two rows, 
which are counts (in the range 0-9), the CPRS-R: L ratings are T scores (mean = 50, SD = 10). 
In the present study, these procedures were used to test 
children and adolescents with a clinical diagnosis of 
ADHD (corresponding to ICD-10 hyperkinetic 
disorder) and typically developing age and sex matched 
controls. Medication for ADHD has traditionally been 
with indirect dopamine agonists, of which 
methylphenidate is the most commonly used drug 
[18,19]. The participants with ADHD tested in the 
present study were all medicated with methylphenidate. 
In animal studies, conditioned inhibition is enhanced 
by treatment with amphetamine [20]. Thus, in addition 
to examining the prediction that conditioned inhibition 
would be impaired in ADHD, we examined the effect 
of dose and duration of treatment with 
methylphenidate. 
2. Methods  
2.1. Participants 
This study fully conformed to international guidelines 
on the ethical conduct of experimental work with 
human participants, as implemented in the UK. Ethical 
approval was obtained from the local research ethics 
committee and the R&D Departments of the 
Nottinghamshire and Lincolnshire Partnership NHS 
Trusts (Derbyshire REC, 08/H0401/34, approved April 
2008). After a complete description of the study, 
written informed consent and verbal assent was 
obtained from parents and children respectively.  
 
2.1.1. ADHD group 
12 Children and adolescents with a clinical diagnosis 
of ADHD (12 males: mean age = 13 years 11 months; 
range = 11 years 9 months – 16 years 9 months) were 
recruited for the current study. The sample was part of 
a larger separate study, reported elsewhere [21,22]. 
Briefly, parents of children and adolescents with a 
diagnosis of ADHD were asked to attend an 
assessment session in which a battery of measures 
including the Development and Well Being 
Assessment (DAWBA; [23]), Strengths and 
Difficulties Questionnaire (SDQ; [24,25]), Conners‟ 
long form (CPRS-R: L; [26]) and Social and 
Communications Questionnaire (SCQ; [27]) were 
administered. Teacher completed versions of the 
DAWBA, SDQ and the CPRS-R: L were also available 
for each child. This, along with a review of medical 
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records formed the basis for a clinical consensus 
diagnostic meeting, in which diagnosis was confirmed 
or overturned. Only children with an established 
positive response to methylphenidate and combined 
type ADHD were included. Any children with Tourette 
Syndrome (TS), pervasive developmental disorder, 
learning disability (defined as a full-scale intelligence 
quotient (FSIQ) <70), or psychosis were excluded. The 
demographic characteristics, details of medication with 
methylphenidate, and the symptom scores (CPRS-R: L) 
of the ADHD participants tested are summarised in 
Table 1. 
2.1.2. Control group  
Of the 35 controls tested, 11 were matched for age (±6 
months) and sex with the ADHD participants and 
included in the study (11 males: mean age = 13 years 
11 months; range = 11 years 7 months - 17 years 1 
month). The control participants were screened for 
probable attentional problems using the Strengths and 
Difficulties Questionnaire [24], and asked whether they 
had any family members who had ADHD (although 
there was no formal assessment for psychiatric 
conditions) prior to testing. The matched control 
participants selected for inclusion in the study did not 
report difficulties indicative of any undiagnosed 
illness; similarly, none reported taking psychotropic 
medication for ADHD, or any other condition.  
IQ scores were not available for all control participants. 
The IQ range of the participants with ADHD (n = 12) 
was 75-108 and 102-107 in the age-matched controls 
for whom IQ scores were available (n = 5). All of the 
participants with ADHD were on medication (Concerta 
– an extended-release preparation of methylphenidate) 
at the point of testing. Participant details are 
summarised in Table 1.  
2.2. Materials 
The task programmes were produced using E-prime 
(Psychology Software Tools Inc., Pittsburgh, USA) 
running on personal computers with 17” monitors, or 
on a 15” laptop computer when travel to the participant 
was required for testing. Participants‟ responses were 
made using a mouse.  
2.3. Procedure 
Behavioural procedures were identical to those used to 
test young participants with TS [16]. 
2.3.1. Conditioned inhibition task 1: ‘Mission 
to Mars’  
The task scenario was based on a hypothetical mission 
to Mars and has been described in full elsewhere 
[16,17]. Participants were informed that they were to 
play the role of a commander of a fleet of starships 
travelling on an exploratory mission to Mars. However, 
trouble arises as, during the course of this mission, 
spaceships in the fleet keep mysteriously exploding.  
The training phase consisted of 45 learning trials of the 
types shown in Table 2. During the training phase there 
were no explicit learning instructions; participants were 
simply asked to carefully count the number of 
surviving rockets. 
There were 9 presentations of 5 trial types, which used 
different CSs presented with or without the CI: CSa+, 
[CI, CSa]-, CSb+, [CI, CSb]-, and CSt+, where “+” 
signified reinforcement (i.e. rocket UCS presentation), 
and “-” signified non-reinforcement (i.e. no rocket 
UCS presentation, represented as an exploded rocket). 
The 5 trial types were presented in a random order. As 
the masking task, participants were required to keep 
track of the number of surviving spaceships, so that the 
associations to be learned were less obvious. On non-
reinforced trials, a 1-second grey frame surrounding a 
blue screen was presented. This was the CI. On 
excitatory trials, there was a 1-second presentation of 
an empty blue screen (at the equivalent point in the 
stimulus sequence). Next, the CS (a large planet) was 
followed by 3 distractors (smaller planets) appearing 
and disappearing on the same screen for a combined 
total of 4 seconds, then the UCS (i.e. rocket 
presentation) on reinforced trials, or the absence of the 
UCS (i.e. exploded rocket presentation) on non-
reinforced trials. The purpose of the distractor stimuli 
was to mask the absence of the CI cue and to control 
for external inhibition. The distractors were also 
intended to reduce the likelihood of direct associations 
between the inhibitor and the absence of the US, as this 
was represented as an alternative outcome. Participants 
were required to press any button on the mouse to 
continue on to the next presentation.  
 
Table 2: The stimulus combinations presented 
during the training and testing phase of the two 
tasks.  
Training Phase Testing Phase 
CSa +   CSt+ 
[CI, CSa]- [CI, CSt]- 
CSb+ Sg+ 
[CI, CSb]- [CI, Sg]- 
CSt+   
Legend: A „+‟ indicates the presentation of the UCS (i.e. an intact 
rocket for the Mission to Mars and a picture of Wolverine for the 
Weapon X task). A „-‟ indicates the absence of the UCS (i.e. an 
exploded rocket for the Mission to Mars and a picture of Feral Logan 
for the Weapon X task). 
The testing phase immediately followed on from the 
training phase and consisted of 20 further trials. There 
were 5 presentations of 4 trial types: Sg+, [CI, Sg]-, 
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CSt+, and [CI, CSt]-, in which Sg was a generalised 
stimulus not previously introduced during the training 
phase (described above). The 4 trial types were 
presented in a random order. The procedure for test 
trials was identical to that used in training, except that 
prior to the presentation of the US (or its absence), 
participants were presented with an on-screen rating, 
scaled 1-9. At this point, participants were required to 
estimate the likelihood of the spaceship surviving, with 
a rating of 9 to represent the highest likelihood of 
survival, and a rating of 1 to represent the lowest 
likelihood of survival. An intermediate rating of 5 
represented uncertainty. Ratings were made by 
selecting the appropriate on screen box using the 
mouse. Figure1 shows the stimuli used in the training 
and test phases of the experiment. 
This was a summation test of conditioned inhibition. 
Participants‟ ratings provided a measure of the 
inhibitory properties of the CI using two kinds of test 
stimuli: (1) Sg (a stimulus that was from the same 
category but had not been explicitly pre-trained); and 
(2) CSt (a stimulus familiar from training, but that had 
not previously been preceded by the CI).  
 
Figure 1: The screen shots used during the Mission 
to Mars task.  
 
Legend: Upper panel shows the blank screen presented in the 
absence of the inhibitor followed by the unconditioned stimulus (US) 
presentation and the alternative framed screen with a grey border 
used on inhibited trials followed by the absence of the desired US, 
depicted as an exploded rocket. The middle panel shows the 
alternative conditioned stimuli (CSs) including the inhibited transfer 
stimulus (CSt) and the generalised stimulus (Sg). The bottom panel 
shows the distractor stimuli used to control for external inhibition. 
 
2.3.2. Conditioned inhibition task 2: 
‘Weapon-X’  
This task presented a scenario based on the Weapon-X 
comic book story and has been described in full 
elsewhere [16]. Participants were informed that they 
were to play the role of Professor Thorton, Director of 
the Weapon-X project, with the job to create the 
ultimate living weapon, using metallurgic skeletal 
bonding to convert Logan into Wolverine. Failure 
results in the feral mutation of Logan. Participants were 
further informed that in order to learn Thorton‟s secret, 
they were to carefully observe his work in order to 
work out the causes of success (Wolverine) versus 
failure (the feral mutation). Thus, they were explicitly 
instructed to try to discover the cause of the outcome. 
As for the previous task, the training phase consisted of 
45 learning trials, presented as 9 presentations of the 5 
trial types shown in Table 2. The stimuli were different 
in that in this task variant, participants were asked to 
observe a computer simulation of the Weapon-X 
transformation. This consisted of 3 stimuli appearing 
simultaneously: the CI (represented by a yellow 
syringe) or its absence (when instead one of three 
alternative syringes was presented, see Figure 2 upper 
panel), the CS (a block of a certain fictitious alloy), and 
one of the five distractors (various types of radiation, 
see Figure 2 lower panel), for a total of 4 seconds on 
screen. The purpose of the alternative syringe stimuli 
was to mask the otherwise notable absence of the CI 
cue and to control for external inhibition (as above). 
The radiation distractors were to further reduce the 
likelihood of direct associations between the inhibitor 
and the absence of the US, as this was represented as 
an alternative outcome. These images were followed by 
a 1 second presentation of an image of Logan in the 
midst of the attempted transformation, then the 
presentation of the US (or its absence). The success or 
failure of the metallurgical bonding was represented by 
an image of Wolverine as the UCS, or a picture of feral 
Logan representing the absence of the UCS.  
 
Figure 2: The screen shots used during the Weapon-
X task. 
 
Legend: Upper panel shows alternative syringe stimuli shown in the 
absence of the inhibitor followed by the unconditioned stimulus (US) 
presentation and the syringe presented on inhibited trials followed by 
the absence of the desired US, depicted as the unsuccessful 
transformation. The middle panel shows the alternative conditioned 
stimuli (CSs) including the inhibited transfer stimulus (CSt) and the 
generalised stimulus (Sg). The bottom panel shows the distractor 
stimuli used to control for external inhibition. 
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Participants were required to press any button on the 
mouse to continue. As above, the testing phase 
consisted of 20 further trials (as per Table 2) with the 
key generalised (Sg) and transfer stimuli (CSt) for the 
summation test of conditioned inhibition. The 
procedure for test trials was identical to that used in 
training, except that prior to the presentation of the US 
or its absence, participants were presented with an 
onscreen rating on the scale 1-9, with 9 representing 
the highest likelihood of success. All choices were 
made by selecting the appropriate box on screen using 
the mouse. Figure 2 shows the stimuli used in the 
training and test phases of the experiment. 
 
All participants were tested on both task variants, in a 
counterbalanced order, so practice effects could not 
account for any difference in performance on the two 
tasks. 
2.3.3. Design and analysis 
Analysis of variance (ANOVA) was run in a mixed 
design with up to four within-subjects factors to assess 
conditioned inhibition by participants‟ summation test 
performance: inhibition (the presence or absence of the 
CI); task (Mission to Mars versus Weapon-X); stimulus 
type (summation test with Sg versus CSt); test phase 
presentation (of which there were five levels). To 
improve focus, analyses were subsequently collapsed 
by stimulus type and test phase presentation where 
these factors did not interact with inhibition [28]. 
Diagnosis was the between subjects factor.  
In order to investigate any possible effects of 
medication, median split analyses were conducted with 
respect to duration of medication (with correction for 
participant age) and the dosage of medication (mg/kg). 
These were distinct parameters in that duration and 
dose of medication were not correlated (see below). 
Median split analysis was also used to examine the 
effect of symptom severity (measured using the CPRS-
R: L) on the expression of conditioned inhibition. The 
dependent variable to assess the expression of 
associative learning was the participants‟ expectancy 
score (for appearances of an intact rocket in task 1 or 
the successful transformation of Logan into Wolverine 
in task 2). Planned comparisons (two-tailed t-tests) 
were conducted to examine effects of a priori interest. 
In addition, effect sizes of likely interest are reported 
(Cohen‟s d).  
A conditioned inhibition ratio was calculated by 
dividing the average expectancy score for non-inhibited 
stimulus presentations by the average expectancy score 
for inhibited stimulus presentations. Thus, conditioned 
inhibition is indicated by a ratio greater than one and 
the absence of conditioned inhibition by a ratio less 
than or equal to one. The interrelationship between the 
level of conditioned inhibition summarised by the ratio 
and symptom severity scores (measured by the CPRS-
R: L) was explored by Pearson‟s r correlation, 2-
tailed. Where data were available (for all ADHD 
participants and 5 matched controls), the same analyses 
were repeated to examine summation test performance 
on each of the tasks in relation to IQ. Similarly, the 
effect of medication was further examined by 
correlational analysis, using duration of medication, 
duration of medication adjusted for age (months on 
medication divided by the age of the participant) and 
medication dosage (mg/kg).  
3. Results 
Analysis with respect to the diagnostic groups (ADHD 
and matched controls), confirmed that there was a 
significant main effect of inhibition (F1,21 = 24.782, p < 
0.001). However, there was no significant interaction 
between diagnostic group and inhibition (F1,21 = 0.763). 
Neither was there any interaction between task, 
inhibition and diagnostic group (F1,21 = 0.029). Both the 
matched controls (t11 = 3.624, p < 0.005, d = 2.16) and 
the ADHD group (t11 = 3.374, p < 0.01, d = 1.94) 
demonstrated an overall effect of inhibition at the 
summation test (Figure 3). There were no significant 
interactions between inhibition or diagnostic group 
with respect to either stimulus, and/or presentation 
(max F1, 21 = 1.906, p = 0.182). However, there was a 
marginal task by inhibition interaction (F1,21 = 4.11, p = 
0.055) reflecting better performance in the Weapon-X 
than in the Mission to Mars task.  
 
Figure 3: The overall effect of inhibition in the 
ADHD and matched control group. 
 
Legend:  Mean Response refers to the participants‟ expectancy 
ratings (scaled 1-9) with a rating of 9 to represent the highest 
likelihood of the outcome (see text for further details). ** = p < 0.01. 
The analysis of effects by medication was confined to 
the ADHD group alone. As expected, the effect of 
inhibition remained significant (F1,11 = 11.384, p < 
0.01). Since there were again no significant interactions 
between inhibition and stimulus or presentation (max 
F1,21 = 1.388), all further analyses were collapsed 
across the factors of stimulus and presentation. 
However, analyses were conducted separately by task 
because of the difference by task identified above. 
Figure 4 shows that participants who were below or 
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equal to the median for medication dose, or duration 
of medication (with or without adjustment for age) did 
not show significant conditioned inhibition in either 
task variant (max t5 = 1.955, d = 0.99). In contrast, 
significant summation test discrimination was 
demonstrated in the Weapon-X task variant by 
participants above the median dose (t5 = 5.167, p < 
0.01, d = 4.5), or above the median duration of 
medication (with or without adjustment for age, t5 = 
3.042, p < 0.05, d = 2.62). Figure 4 shows that, in the 
Weapon-X task, non-inhibited and inhibited ratings 
were respectively higher and lower above the median 
medication parameters. However, the only significant 
change was for the non-inhibited ratings in relation to 
dose (t10 = 2.237, p < 0.05, d = 1.41). No other 
differences between the inhibited and non-inhibited 
ratings reached significance (max t10 = 1.341, d = 
0.85). 
Although somewhat increased in those participants 
with longer duration of treatment, the improvements in 
summation test discrimination demonstrated above the 
median medication parameters were not significant in 
the Mission to Mars task variant (max t5 = 1.671, d = 
1.4).  
Again within the ADHD group, there was no 
interaction between symptom level (median split on the 
CPRS-R: L ratings) and inhibition or inhibition by task 
(max F = 0.666). Thus, high and low symptom 
participants showed equivalent summation test 
discrimination. Nevertheless, participants may have 
shown individual variation on the task in relation to 
symptom severity. To address the likely confound 
between medication status and ADHD symptom 
severity, ANCOVA was applied to the median split 
analyses for the ADHD group, using the ADHD index 
of the CPRS-R: L as covariate. 
There were no significant interactions between dose 
and inhibition (max F1, 9 = 1.629). However, a 
significant interaction between duration of medication 
and inhibition was found (F1,9 = 5.748, p < 0.05). 
Inspection of the adjusted means shows that when 
symptom severity was taken into account, overall 
summation test discrimination was more pronounced in 
participants above the median duration of medication 
(mean inhibited ratings = 3.37, s.e.m. = 0.526; mean 
non-inhibited ratings = 7.519, s.e.m. = 0.405) 
compared with summation test discrimination seen in 
participants below the median time on medication 
(mean inhibited ratings = 4.747, s.e.m. = 0.526, mean 
non-inhibited ratings = 5.922, s.e.m. = 0.405). 
Repeating the analysis with duration of medication 
adjusted for age yielded the same outcome. No other 
interactions were significant (max F < 1).  
Due to the design of the two tasks, no data were 
collected during the training phase of the procedure. 
However, in order to analyse whether participants 
demonstrated equivalent levels of learning at the end of 
the training phase, the ratings from the first 
presentation of the non-inhibited transfer stimulus 
during the test phase were analysed. Univariate 
ANOVA of the first presentation ratings demonstrated 
no significant difference between the ADHD group and 
the matched controls overall, for the Weapon-X task (F 
= 0.271), the Mission to Mars task (F 1, 21 = 2.248), or 
over both tasks combined (F = 0.266). 
Moreover, in order to test whether learning under 
methylphenidate had affected baseline excitatory 
learning, the analysis was repeated with medication 
dosage (median split) and duration of medication 
(median split) as the between subject variables. 
 
Figure 4:  The effects of medication on summation 
test discrimination within the ADHD group. 
(A) ADHD group: differences by medication dosage.  
A  
(B) ADHD group: differences by duration of 
medication. 
B 
(C) ADHD group: differences by duration of 
medication adjusted for age  
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Legend: Effects of medication shown separately for the two task 
variants, with respect to (panel A) below or equal versus above 
median dosage [mg/kg], (panel B) below or equal versus above 
median duration of medication and (panel C) below or equal versus 
above median duration of medication adjusted for age (* = p < 0.05, 
** = p < 0.01, *** = p < 0.001). Mean Response refers to the 
participants‟ expectancy ratings (scaled 1-9) with a rating of 9 to 
represent the highest likelihood of the outcome (see text for further 
details).  
Univariate ANOVA of the first presentation ratings 
demonstrated no significant difference between the two 
medication dosage groups for the Weapon-X task (F = 
0.156), the Mission to Mars task (F = 0.015), or over 
both tasks combined (F = 0.084). Likewise, there were 
no significant differences between the duration (high 
vs. low) of medication groups for the Weapon-X task 
(F 1, 10 = 1.607), the Mission to Mars task (F = 0.015), 
or over both tasks combined (F = 0.236). 
3.1.1. Correlational analyses  
Within the ADHD sample, there was no significant 
correlation between dose or duration of medication and 
performance on either task as summarised by the 
conditioned inhibition ratios (max r12 = -0.408). Dose 
and duration were distinct medication parameters in 
that there was no correlation between medication 
dosage and participants‟ time on medication (r12 = -
0.168). In addition, there was no correlation between 
medication dosage and participants‟ time on 
medication adjusted by age (r12 = -0.115), or between 
symptom severity measured by the CPRS-R: L (either 
overall or by its subscales; max r12 = -0.511), or 
between IQ and the summary scores provided by the 
conditioned inhibition ratios for either task (max r12 = -
0.549). Similarly, the overall correlation between 
conditioned inhibition and IQ across both the ADHD 
and matched controls for whom IQ scores were 
available was also non-significant for both task variants 
(max r17 = -0.426).  
4. Discussion 
Two variants of the summation test showed that 
inhibition was transferred to a CS that had not been 
previously presented with the CI during training (CSt) 
as well as to a novel stimulus from the same category 
to which excitatory responding was generalised (Sg) 
[14]. Moreover, conditioned inhibition was tested using 
two task variants. The first (Mission to Mars) was a 
modified version of an established task, which used 
serial presentation of the CI followed by CSt or Sg [17]. 
The second (Weapon-X) was a novel task, similarly 
designed to be engaging for younger participants, 
which used simultaneous presentation of the CI  
together with CSt or Sg. Since the originally developed 
task tested learning implicitly, the novel task variant 
used explicit learning instructions, to further confirm 
the generality of observed effects.  
Conditioned inhibition was successfully demonstrated 
in all participants in the present study. Thus, young 
males with ADHD can successfully suppress S-S 
associations. However, there was variation within the 
ADHD group, in that participants on either a higher 
dosage or longer duration of treatment with 
methylphenidate showed improved performance and, 
consistent with some overall difference in inhibition by 
task, this effect was most clearly demonstrated in the 
Weapon-X variant. The difference took the form of 
improved summation test discrimination, but the 
improvement was not solely attributable to lower 
ratings given on inhibited stimulus presentations.  
Summation test performance reflects the expression of 
prior learning. The course of acquisition was not 
directly assessed in the training phases of the tasks due 
to the implicit nature of the Mission to Mars task and 
the need to keep the tasks formally equivalent as far as 
possible. Analysis of first test trial responding to CSt, 
which was used as the best estimate of (effects on) 
excitatory learning did not show any effect of 
diagnostic group or medication status. Although the 
profile of action on the summation test is consistent 
with generally improved associative learning under 
methylphenidate, the present results only allow the 
conclusion that the expression of prior learning was 
improved under methylphenidate. Moreover, there 
were differences by task in that the accentuated 
summation test performance only reached significance 
in the Weapon-X variant (see also below). 
4.1. Effects of symptom severity and IQ 
There was no detectable correlation between the 
CPRS-R: L scores of the ADHD participants (either 
overall or by its subscales) and the level of inhibition 
demonstrated in either task variant. This lack of 
correlation between symptom severity and conditioned 
inhibition could be due to a ceiling effect, given the 
relatively restricted range of scores in the patient 
sample who all met diagnostic criteria for ADHD, 
and/or the limited sample size. However, there was 
some indication in the data that the effect of medication 
was more than would be expected on the basis of 
symptom severity: when symptom severity was taken 
into account statistically (by analysis of covariance), 
there was an interaction between duration (but not 
dose) of medication and inhibition - in this case overall 
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rather than separately by task. This result shows that, 
when symptom severity was taken into account, the 
summation test discrimination was improved overall in 
participants treated with methylphenidate over a longer 
time frame. 
While a number of the participants with ADHD had a 
lower than average IQ, there was no correlation 
between IQ and the level of inhibition demonstrated, 
either within the ADHD sample, or including the 
matched controls where data were available. 
Conventional tests of inhibition used with ADHD 
participants (the stop signal, the Go/No-Go and a 
modified version of the Stroop task), similarly showed 
a deficit in relation to ADHD, but no association with 
IQ [29]. In the present study, it was not possible to 
match controls on the basis of IQ, as IQ scores were 
not available for all participants. However, there are 
arguments against matching on the basis of IQ in that 
disorders such as ADHD are a likely cause of 
depressed IQ: the matching fallacy whereby 
participants may be „overmatched‟ on variables which 
are not independent of the disorder in question [8]. 
 
4.2. Differences by task 
Although conditioned inhibition was overall 
demonstrated in both task variants, performance was 
generally better on the Weapon-X variant. This 
difference may arise because the storyline of the latter 
task was intrinsically more engaging for the young 
males tested in the present study, or because the use of 
explicit learning instructions influences task solution 
[30,31]. Alternatively, some advantage on the Weapon-
X task may have been conferred by the simultaneous 
rather than serial presentation. Serial or „occasion 
setting‟ versions of conditioned inhibition tasks 
provide a more direct analogue of response learning 
tasks, where the required association is qualified by 
discriminative stimuli (e.g., Go/No-Go). However, they 
may be generally more difficult. Animal studies have 
similarly indicated that the effectiveness of a stimulus 
as an inhibitor can depend on its temporal positioning 
with respect to potential excitors, and specifically that 
simultaneous rather than serial training more reliably 
results in conditioned inhibition as measured by 
summation test [32,33]. 
4.3. Differences by medication 
In participants with TS, medication with clonidine was 
found to impair the expression of conditioned 
inhibition, measured using identical procedures [16]. In 
the current study, the entire sample of ADHD 
participants was medicated. Moreover, the level of 
conditioned inhibition was not equivalent across the 
two tasks, and the ADHD group did not show 
significant conditioned inhibition on the Mission to 
Mars task. Accordingly, within the ADHD sample, the 
effects of medication were examined separately by 
task. Correlational analyses did not suggest any linear 
relationship between the level of conditioned inhibition 
and medication dose or duration in either task variant. 
However, median split analyses to divide the ADHD 
group into low v. high dose and short v. long duration 
of treatment showed that (according to either of these 
medication parameters) treatment with methyl-
phenidate tended to improve expression of the 
conditioned inhibition discrimination measured at the 
summation test, significantly so for the Weapon-X 
task. This difference by conditioned inhibition variant 
appears related to task difficulty, in that the Weapon-X 
task supported a stronger conditioned inhibition effect 
(presumably in consequence of its explicit learning 
instructions and simultaneous rather than serial 
presentation of the CI in relation to CSt and Sg). The 
Weapon-X task also supported better performance in 
the unmedicated controls.  
In animal studies too, methylphenidate has been found 
to increase simple associative learning [34,35]. The 
neural substrates of specifically inhibitory learning 
have been little investigated to date, but the effect of 
amphetamine is to enhance conditioned inhibition [20]. 
This finding is similarly consistent with the possibility 
of differences in relation to ADHD and its medication 
with indirect dopamine agonists.   
4.4. Conclusions  
The participants with ADHD tested in the present study 
were all medicated with methylphenidate; treatment 
was thus confounded with diagnosis. Moreover, 
differences may have been masked by ceiling effects, 
since participants were selected on the basis of high 
scores on the CPRS-R: L scale. Thus, the relationship 
between symptom severity and performance in the 
conditioned inhibition tasks should be further 
investigated in a larger, more heterogeneous sample. 
Relatedly, our procedures were not suitable for repeat 
testing with the same task and the effects of medication 
point to the need to test the hypothesis that the 
inhibition of S-S associations should be impaired in 
ADHD when medication is withdrawn. However, 
effects on the expression of associative learning in 
relation to medication in ADHD are nonetheless of 
interest. Participants below the median dose or duration 
of treatment with methylphenidate showed no 
discrimination on the summation test, whereas the 
summation test discrimination was significant above 
these medians with a small to medium effect size (ds of 
4.5 and 2.62, respectively). 
Methylphenidate has previously been reported to 
improve the capacity to inhibit ongoing and prepotent 
responses in conventional tests of response inhibition, 
including the Stroop [36] and variants of the stop signal 
task [37]. Although the present study demonstrated 
improved performance of the key summation test 
discrimination in a conditioned inhibition procedure, 
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this result cannot be taken to reflect enhanced 
inhibition of S-S associations under methylphenidate 
because the improvement in discrimination 
performance had two components. Moreover, only the 
change in non-inhibited ratings reached significance 
(for the Weapon-X task, when the sample was split on 
the dosage parameter). Thus, although there was no 
evidence of drug effects on excitatory learning, as 
measured by trial 1 responding to the CSt, neither was 
there any evidence that the improved summation test 
discrimination arose because of a change in inhibitory 
as distinct from excitatory learning. We therefore 
conclude that methylphenidate improved the 
expression of associative learning in general, and 
suggest that this action may contribute to its 
therapeutic effects in improving cognitive function in 
ADHD. 
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